|
Real-time Estimate
Cboe Europe
06:48:18 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 114.40 GBX | -1.21% |
|
-0.52% | -8.80% |
| 10-19 | PureTech Health to announce clinical trial results in Madrid | AN |
| 10-07 | Dillistone new strategy; Oriole Resources maiden MRE | AN |
Company Valuation: PureTech Health plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,138 | 894.5 | 672.5 | 450.2 | 406.6 | 379.5 | - | - |
| Change | - | -21.39% | -24.82% | -33.05% | -9.69% | -6.67% | - | - |
| Enterprise Value (EV) 1 | 724.2 | 559.8 | 455.5 | 101.7 | 133.9 | 148.7 | 209.2 | 346.7 |
| Change | - | -22.7% | -18.63% | -77.68% | 31.68% | 11.1% | 40.61% | 65.78% |
| P/E | -18.8x | -17.8x | -10.3x | 8.95x | -3.66x | -3.28x | -3.33x | -6.19x |
| PBR | - | - | - | - | - | 0.02x | 0.02x | 0.02x |
| PEG | - | 1.2x | -0.3x | -0x | 0x | -1.21x | 2.25x | 0.1x |
| Capitalization / Revenue | 65.4x | 57.3x | 202x | 93.2x | 87.3x | 47.3x | 26.7x | 11.2x |
| EV / Revenue | 41.7x | 35.8x | 137x | 21.1x | 28.7x | 18.6x | 14.7x | 10.2x |
| EV / EBITDA | -5.06x | -2.96x | -3.22x | -0.77x | -1.41x | -1.69x | -2.86x | -10.2x |
| EV / EBIT | -4.82x | -2.83x | -3.12x | -0.75x | -1.36x | -1.6x | -3.06x | -11.2x |
| EV / FCF | - | -3.01x | -4.3x | -0.76x | -1.57x | -1.68x | -2.78x | -11x |
| FCF Yield | - | -33.2% | -23.3% | -132% | -63.6% | -59.5% | -36% | -9.08% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.21 | -0.18 | -0.24 | 0.21 | -0.46 | -0.4725 | -0.4655 | -0.25 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 17.39 | 15.62 | 3.33 | 4.828 | 4.659 | 8.017 | 14.23 | 33.87 |
| EBITDA 1 | -143 | -188.9 | -141.3 | -132.5 | -95.18 | -88.11 | -73.1 | -33.89 |
| EBIT 1 | -150.3 | -197.8 | -146.2 | -136.1 | -98.53 | -92.75 | -68.33 | -30.91 |
| Net income 1 | -60.56 | -50.35 | -65.7 | 53.51 | -109.7 | -134.6 | -119 | -53.5 |
| Net Debt 1 | -413.7 | -334.7 | -217 | -348.5 | -272.7 | -230.7 | -170.3 | -32.76 |
| Reference price 2 | 3.954 | 3.211 | 2.474 | 1.880 | 1.682 | 1.548 | 1.548 | 1.548 |
| Nbr of stocks (in thousands) | 287,797 | 278,566 | 271,854 | 239,421 | 241,684 | 245,180 | - | - |
| Announcement Date | 4/26/22 | 4/28/23 | 4/25/24 | 4/30/25 | 4/29/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.28x | 18.55x | -1.69x | - | 379M | |
| 18.38x | 6.48x | 12.88x | 1.62% | 63.29B | |
| 30.22x | 7.94x | 26.49x | 0.05% | 54.89B | |
| 36.58x | 6.5x | 19.41x | 0.88% | 53.28B | |
| 35.46x | 3.44x | 14.83x | -.--% | 45.81B | |
| 50.32x | 5.82x | 31.95x | -.--% | 43.46B | |
| -19.48x | 188.5x | -20.74x | -.--% | 40.23B | |
| 29.02x | 8.23x | 21.28x | 0.37% | 33.45B | |
| 27.38x | 5.77x | 14.95x | -.--% | 23.7B | |
| 32.79x | 5.99x | 20.16x | -.--% | 23.76B | |
| Average | 23.74x | 25.72x | 13.95x | 0.32% | 38.23B | |
| Weighted average by Cap. | 26.68x | 25.50x | 15.91x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PRTC Stock
- Valuation PureTech Health plc
Select your edition
All financial news and data tailored to specific country editions
